RNA targeting unleashes indiscriminate nuclease activity of CRISPR–Cas12a2

January 31, 2023

Title

RNA targeting unleashes indiscriminate nuclease activity of CRISPR–Cas12a2

Author

Jack P. K. Bravo, Thomson Hallmark, Bronson Naegle, Chase L. Beisel, Ryan N. Jackson & David W. Taylor

Year

2023

Journal

Nature

Abstract

Cas12a2 is a CRISPR-associated nuclease that performs RNA-guided, sequence-nonspecific degradation of single-stranded RNA, single-stranded DNA and double-stranded DNA following recognition of a complementary RNA target, culminating in abortive infection1. Here we report structures of Cas12a2 in binary, ternary and quaternary complexes to reveal a complete activation pathway. Our structures reveal that Cas12a2 is autoinhibited until binding a cognate RNA target, which exposes the RuvC active site within a large, positively charged cleft. Double-stranded DNA substrates are captured through duplex distortion and local melting, stabilized by pairs of ‘aromatic clamp’ residues that are crucial for double-stranded DNA degradation and in vivo immune system function. Our work provides a structural basis for this mechanism of abortive infection to achieve population-level immunity, which can be leveraged to create rational mutants that degrade a spectrum of collateral substrates.

Instrument

J-1500

Keywords

RNA, nuclease activity, CRISPR–Cas12a2